BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Genentech Defends Supply Shift For Top Cancer Drugs     11/25/2014
Cell Medica Rakes In $78 Million Series B To Advance Cancer Program     11/25/2014
GlaxoSmithKline Shareholders To Vote On Novartis AG Deal On Dec. 18     11/24/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme, Says Citi     11/21/2014
Pfizer, Merck KGaA Strike A $2.9B Deal To Develop Cancer Tumor Treatment     11/18/2014
AstraZeneca PLC Shows Off Strong Drug Pipeline As Pfizer Deadline Looms     11/18/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
Merck & Co. Announces Positive Study Investigating The Use Of KEYTRUDA® (pembrolizumab) Compared To Chemotherapy In Patients With Ipilimumab-Refractory Advanced Melanoma     11/17/2014
Puma Biotechnology's Cancer Drug Neratinib Fails Mid-Stage Study     11/14/2014
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA), BioMarin Pharmaceutical Inc. and Tesaro, Inc. To Most Preferred     11/14/2014
Gilead Sciences, Inc. Poised To Be One Of The Most Remarkable Growth Stories In Biotech, Says Analyst     11/11/2014
Citi: Esperion Therapeutics, Inc. Will See Cancer Drug Data By End Of Year     11/11/2014
Analyst: Celgene’s Drug Pipeline Will Be The Gift That Keeps On Giving     11/10/2014
Citi: Agios Pharmaceuticals’s Experimental Cancer Drug Could Provide Major Upside     11/10/2014
Novartis AG's Panobinostat Fails To Win FDA Panel Support     11/7/2014
 Featured Stories
The Dirty Side Of Soap, University of California, San Diego (UCSD) Study     11/19/2014
Walnuts Slow Prostate Cancer In Mice, University of California, Davis (UCD) Study     11/18/2014
University of North Carolina Researchers Silence Leading Cancer-Causing Gene     11/18/2014
Lactose Intolerants Linked To Lower Cancer Risk, Lund University Study     11/6/2014
Long Term Shift Work Linked To Impaired Brain Function, Occupational & Environmental Medicine Reveals     11/5/2014
Saliva May Reveal Deadly Diseases Early Enough To Treat Them, University of California, Los Angeles (UCLA) Scientists Report     10/31/2014
Tea And Citrus Products Could Lower Ovarian Cancer Risk, New University of East Anglia Research Finds     10/29/2014
Finally: A Missing Link Between Vitamin D and Prostate Cancer, University of Colorado Study     10/24/2014
Y Chromosome Linked To Cancer And Death Risk In Men, Uppsala Universitet Study     10/23/2014
Drinking Two Sodas A Day Can Age You 4 Years, University of California, San Francisco (UCSF) Study     10/21/2014
Thyroid Carcinoma: Biomarker Reveals Cancer Cause, Helmholtz Zentrum Munchen Study     10/14/2014
Americans Living Longer As Fewer Die From Heart Disease, Cancer, CDC Reveals     10/13/2014
Hormone That Keeps Us Alert Also Suppresses The Spread Of Cancer, Weizmann Institute of Science Reveals     10/9/2014
New Blood Test Shows Who Has And Who May Get Cancer, University Of Bradford Study     10/3/2014
Tattoo Ink Linked To Skin Cancer Risk, PRS Global Open Reveals     9/23/2014
 More News
St. Jude Children's Research Hospital Release: Survivors Of Childhood Eye Cancer Experience Normal Cognitive Functioning As Adults     11/24/2014
Polaris Group Announces Treatment Of First Patient In Phase 1 Study Of ADI-PEG 20 Plus Pemetrexed And Cisplatin In Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma     11/20/2014
Tokai Pharmaceuticals (TKAI) Presents Updated Interim Galeterone ARMOR2 Data Showing Activity In Patients With Castration-Resistant Prostate Cancer (CRPC) Including Those Showing A Variant Form Of Prostate Cancer Resistant To Hormone Therapy     11/19/2014
Puma Biotechnology (PBYI) Announces Positive Top Line Results From PB272 Phase 2 Trial In HER2 Positive Metastatic Breast Cancer (Nefertt Trial)     11/14/2014
Celiac Disease Center At Columbia University Unveils Video Campaign At 13th Anniversary Gala To Demonstrate The Severity Of Celiac Disease For Patients     11/14/2014
MaxiVAX SA Release: Swiss Biotech Starts Breakthrough Anti-Cancer Clinical Trial Based On Active Immunotherapy     11/13/2014
Quiet Therapeutics Co-Founders Prof Dan Peer And Prof Rimona Margalit Receive Award For Groundbreaking Work In Targeted Nanoparticles For Cancer     11/13/2014
Caris Life Sciences Study Shows Molecular Profiling May Expand Use Of PD-1 And PD-L1 Inhibitors To Wide Variety Of Cancers     11/12/2014
Biothera’s Imprime PGG Named To Top 10 List Of Most Interesting Oncology Projects To Watch     11/12/2014
NovoCure Ltd. Announces The Presentation Of New Data At The 19th Annual Society Of Neuro-Oncology Meeting     11/11/2014
Children's Hospital of Philadelphia Release: Classification Of Gene Mutations In A Children's Cancer May Point To Improved Treatments     11/10/2014
Cartagenia Partners With CollabRx, Inc. To Provide Pathology Laboratories And Cancer Centers Access To Personalized Information On Therapeutic Options     11/10/2014
Multiple Bristol-Myers Squibb Company (BMY) Oncology Compounds To Be Featured In Oral Presentations At 56th Annual American Society of Hematology Meeting     11/10/2014
Seattle Children's Research Institute's Begins Recruiting Patients For Immunotherapy Research Trial For Neuroblastoma, One Of The Deadliest Forms Of Childhood Cancer     11/7/2014
Lycera Announces Research Showing Novel, Oral Immunotherapy Possesses Potent Single Agent Anti-Cancer Activity     11/7/2014